BRYAN BALL - 11 Jul 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
Chief Qual. Officer & SVP Ops.
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Jul 2022
Net transactions value
-$6,353
Form type
4
Filing time
13 Jul 2022, 16:01:33 UTC
Previous filing
13 Apr 2022
Next filing
26 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $6,353 -436 -1.7% $14.57 25,178 11 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.